A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo.

A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Abstract Text:

L J Hanka,D G Martin,G L Neil,

A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Publishing Authors By Initials

LJ Hanka,DG Martin,GL Neil,

For similar heterocyclic compounds: heterocyclic compounds, 1-ring: azoles: oxazoles research abstracts see: heterocyclic compounds: heterocyclic compounds, 1-ring: azoles: oxazoles research

PUBMED ID PMID:

MEDLINE DATE:

A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 57

Page Numbers: 141-8

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: Apr

YEAR: 1973

A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Keywords Mesh Terms:

KEYWORDS: Oxazoles

MESH TERMS: blood

Chemical & Substance for Abstract: A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. Information

Substance Name: Oxazoles

Registry Number: 0

Grant and Affiliation Information for A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A new antitumor antimetabolite, alphaS,5S-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid NSC-163501: antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo Related Publications

• A new antitumor agent, (alphas, 4s, 5r)-alpha-amino-3-chloro-4-hydroxy-4,5-dihydro-5-isoxazoleacetic acid (NSC-176324): preliminary evaluation against L 1210 mouse leukemia in vivo.
• A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo.
• Amnesic shellfish poisoning toxins in shellfish: estimation of uncertainty of measurement for a liquid chromatography/tandem mass spectrometry method.
• Anatomy of a disaster: one hospital's experience and recommendations.
• Antileukemic activity of streptozotocin (NSC-85998) and its analogs.
• Application of magnetic resonance imaging in animal models of perinatal hypoxic-ischemic cerebral injury.
• Biochemical studies of virus reproduction; purification and properties of Escherichia coli bacteriophage T6.
• Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
• Cs + ADC in rat brain decreases markedly at death.
• Detection and assay of antitumor antibiotics.
• Diffusion imaging concepts for clinicians.
• Diffusion-tensor MR imaging of normal brain maturation: a guide to structural development and myelination.
• Dissecting aortic aneurysm simulating arterial embolism; report of two cases.
• Dorsal wedge osteotomy of the proximal phalanx for hallux rigidus. Long-term results.
• Improved microbiological assay for cytosine arabinoside (NSC-63878).
• Intracellular water specific MR of microbead-adherent cells: Hela cell intracellular water diffusion.
• Intracellular water-specific MR of microbead-adherent cells: the HeLa cell intracellular water exchange lifetime.
• MHPG excretion and EEG sleep in primary depression.
• Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
• Microstructural changes of the baboon cerebral cortex during gestational development reflected in magnetic resonance imaging diffusion anisotropy.
• Ooplasmic round spermatid nuclear injection procedures as an experimental treatment for nonobstructive azoospermia.
• Organizing for drug discovery.
• Primary leiomyosarcoma of bone.
• Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts.
• Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.
• Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
• Testing the hearing and the assessment of loss of capacity for the hearing of speech.
• The carotid and aortic vasosensory areas; their contribution to circulatory and respiratory adjustments occurring after haemorrhage.
• Tissue distribution of streptozotocin (NSC-85998).
• [Microsurgery and intervertebral fusion with anterior plating for cervical spondylitic radiculopathy]